OTCMKTS:SHTDY Sinopharm Group (SHTDY) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free SHTDY Stock Alerts $13.03 +0.35 (+2.76%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$13.02▼$13.0650-Day Range$11.42▼$14.4452-Week Range$11.36▼$18.01Volume2,528 shsAverage Volume13,913 shsMarket CapitalizationN/AP/E Ratio2.61Dividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartDividendFinancialsHeadlinesShort InterestStock AnalysisChartDividendFinancialsHeadlinesShort Interest Get Sinopharm Group alerts: Email Address Ad Behind the MarketsCentral Banks Preparing for US Dollar Collapse?China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.Find out how you can protect yourself now >>> About Sinopharm Group Stock (OTCMKTS:SHTDY)Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.Read More SHTDY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHTDY Stock News HeadlinesMarch 27, 2024 | markets.businessinsider.comBuy Rating for Sinopharm Group Co. Amidst Market Consolidation and Efficiency GainsMarch 15, 2024 | tmcnet.comXinhua Silk Road: Electric tricycles made in E. China's Rizhao popular abroadMarch 28, 2024 | DTI (Ad)Warning: this could blow your mindBuckle up… ‘Cause this might shatter everything you’ve heard about “income trading”. In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it: The Perfect Income Trade You see, most of the income techniques out there target a couple of percent. Maybe 5 - 10 percent if you’re lucky. But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return. And here’s the best news of all: This trade can target an opportunity like that every week. Every single week. Meaning an investor has the chance to “stack up” these more aggressive income trades over and over. If that sounds interesting…February 25, 2024 | msn.comSinopharm Group Co. - Depositary Receipt () (SHTDY) Price Target Increased by 11.16% to 15.28February 22, 2024 | msn.comHong Kong Stocks: Sinopharm to Buyout China-TCM for HK$23.2BFebruary 21, 2024 | uk.finance.yahoo.comPharma Wholesale and Distribution market is projected to grow at a CAGR of 8.7% by 2034: VisiongainFebruary 19, 2024 | thestreet.comSinopharm Group Co Ltd ADRNovember 7, 2023 | morningstar.comSinopharm Group Co Ltd ADR SHTDYMarch 28, 2024 | Crypto 101 Media (Ad)Major Elon Musk Crypto Leak RevealedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.September 5, 2023 | finance.yahoo.comHong Kong stocks slide amid China property default risk while Sinopharm slides on index debut, L'Occitane crashesMay 18, 2023 | msn.comWHO recommends updating COVID shots to add XBB.1 variantsMarch 30, 2023 | marketwatch.comChlorpheniramine Maleate Market Outlook and Forecast till 2031March 29, 2023 | morningstar.comSinopharm’s Earnings Slightly Better Than ExpectedMarch 29, 2023 | marketwatch.com2023-2029 Gold(III) Bromide (AuBr3) Market Size and Industrial Overview with Region Footprint | Latest Report by Absolute ReportsMarch 28, 2023 | marketwatch.com7-Aminocephalosporanic Acid (7-ACA) Market Outlook By 2031March 27, 2023 | marketwatch.comSpecialty Pharmacy Services Market Outlook By 2031March 24, 2023 | marketwatch.comGosling Plague Vaccine Market Top Players By 2031March 23, 2023 | marketwatch.comNew Report Predicts Significant Growth in Polysorbate 40 Market from 2023 to 2030March 21, 2023 | marketwatch.comGlobal Cobamamide Drugs Market: Future Extrapolations and Emerging Updates for 2023-2027March 21, 2023 | marketwatch.comChain Drugstores Market Top Players and Forecast till 2029March 13, 2023 | marketwatch.comAmmonium Phosphomolybdate Market Size, Share and Forecast 2028 with Top Countries DataMarch 13, 2023 | marketwatch.comChain Drugstores Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2029March 10, 2023 | marketwatch.comTacrolimus Consumption Market Size, Growth Rate, Key Players Share, Trends Analysis with Forecast 2023-2029March 8, 2023 | marketwatch.comPolysorbate 40 Market Size 2023 Will Grow Rapidly Another Level In The Forthcoming Year 2030March 1, 2023 | marketwatch.comGlobal Vinorelbine Tartrate Market Dynamics, Major Players, And Forecast Research 2023 – 2030 By VMReportsFebruary 27, 2023 | marketwatch.comGlobal Chorionic Gonadotrophin Market Share Analysis, Size 2023 for Expansion Plans, Upcoming Trends by Forecast to 2030 By VMReportsFebruary 23, 2023 | marketwatch.comGlobal Gynecological Ozone Therapy Instruments Market Insights, Key Players and Top Factors Driving the Industry 2023 – 2030 By VMReportsSee More Headlines Receive SHTDY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:SHTDY CUSIPN/A CIK1556605 Webwww.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees114,766Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.61 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Qingming Yu (Age 60)Executive Chairman of the Board Comp: $913.26kMr. Yong Liu (Age 55)President & Executive Director Comp: $883.15kMs. Xiaojuan Li (Age 48)Chief Financial Officer Mr. Yijian Wu (Age 54)Secretary to the Board, Company Secretary & Authorised Representative Key CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFEBOS GroupOTCMKTS:EBOSFGalenicaOTCMKTS:GALNFMcKesson EuropeOTCMKTS:CAKFYView All Competitors SHTDY Stock Analysis - Frequently Asked Questions How have SHTDY shares performed in 2024? Sinopharm Group's stock was trading at $13.05 at the beginning of the year. Since then, SHTDY stock has decreased by 0.2% and is now trading at $13.03. View the best growth stocks for 2024 here. Are investors shorting Sinopharm Group? Sinopharm Group saw a increase in short interest in February. As of February 29th, there was short interest totaling 21,900 shares, an increase of 356.3% from the February 14th total of 4,800 shares. Based on an average trading volume of 24,900 shares, the short-interest ratio is currently 0.9 days. View Sinopharm Group's Short Interest. How often does Sinopharm Group pay dividends? What is the dividend yield for Sinopharm Group? Sinopharm Group declared a dividend on Thursday, June 15th. Investors of record on Friday, June 16th will be paid a dividend of $0.4862 per share on Tuesday, August 29th. This represents a yield of 2.85%. The ex-dividend date of this dividend is Thursday, June 15th. Read our dividend analysis for SHTDY. How do I buy shares of Sinopharm Group? Shares of SHTDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHTDY) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.